•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A00317 Summary:

BILL NOA00317
 
SAME ASSAME AS S05095
 
SPONSORWalker
 
COSPNSR
 
MLTSPNSR
 
Add Art 25 Title 4-A §§2576 - 2579, Pub Health L
 
Enacts the "children and recovering mothers (CHARM) act" to provide guidance, education and assistance to healthcare providers caring for expectant mothers with substance use disorder; provides for the screening of newborns for substance abuse exposure.
Go to top    

A00317 Actions:

BILL NOA00317
 
01/04/2023referred to health
01/03/2024referred to health
Go to top

A00317 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A317
 
SPONSOR: Walker
  TITLE OF BILL: An act to amend the public health law, in relation to children and recovering mothers   PURPOSE OR GENERAL IDEA OF BILL: To amend the Public Health Law by establishing the Children and Recover- ing Mothers (CHARM) act.   SUMMARY OF PROVISIONS: Section 1 of the bill creates the Children and Recovering Mothers (CHARM) act. Section 2 amends Article 25 of the Public Health Law by adding a new title 4-A, in relation to children and recovering mothers. This section establishes a recovering expectant mothers' program within the Depart- ment of Health, whereby the Commissioner, in consultation with the Commissioner of Alcoholism and Substance Abuse Services, will assist providers caring for recovering expectant mothers through guidance on universal screening techniques, providing information regarding Medica- tion Assisted Treatment (MAT) for pregnant women, providing referral information for substance abuse counseling, developing a system for consultation and linkage services for obstetricians and primary care providers who care for recovering expectant mothers, developing provider education, and creating a workgroup of stakeholders to evaluate barriers in treating expectant mothers, newborns, and new parents with substance use disorder. Section 3 provides that the act shall take effect on the 90th day after its enactment; provided, however, that effective immediately, any actions necessary for the implementation of the act on its effective date are authorized and directed to be completed on or before the effec- tive date.   JUSTIFICATION: Amid the ever-growing demographic impacted by the opioid epidemic are expectant mothers and their newborns. According to the National Insti- tutes of Health (NIH), there was a five-fold increase in the proportion of babies born with Neonatal Abstinence Syndrome (NAS) from 2000 to 2012, which is the equivalence of one baby being born with opiate with- drawal every 25 minutes. Babies born with NAS had average hospital stays of 16.9 days (an average amount of $66,700) compared to 2.1 days (an average amount of $3,500) for babies born without NAS. These newborns can also suffer from low birth weight, prematurity, sudden infant death syndrome, and other forms of fetal distress at birth. Vermont's Children and Recovering Mothers (CHARM) Collaborative, established in 2002 to provide care coordination services for pregnant women with addiction, MAT, substance abuse counseling services, standard prenatal care, as well as an on-going assessment of the social support needs of these women has greatly helped VT in tackling this important issue. Building upon the principles of the VT program, this NY legislation seeks to educate providers, link pregnant women to care in an effort to address any substance use prior to the birth of the child, decrease the number of babies born with NAS, and to ensure linkage with supports after the child is born.   PRIOR LEGISLATIVE HISTORY: 2019-2020: A7955 - Referred to Health 2021-2022: A4337 - Referred to Health   FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS: To be Determined.   EFFECTIVE DATE: This act shall take effect on the ninetieth day after it shall have become a law; provided, however, that effective immediately, any actions necessary for the implementation of this act on its effective date are authorized and directed to be taken and completed on or before such effective date.
Go to top

A00317 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                           317
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                     January 4, 2023
                                       ___________
 
        Introduced by M. of A. WALKER -- read once and referred to the Committee
          on Health
 
        AN  ACT  to  amend  the  public  health law, in relation to children and
          recovering mothers
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  Short  title. This act shall be known and may be cited as
     2  the "children and recovering mothers (CHARM) act".
     3    § 2. Article 25 of the public health law is amended by  adding  a  new
     4  title 4-A to read as follows:
     5                                  TITLE 4-A
     6                       CHILDREN AND RECOVERING MOTHERS
     7  Section 2576. Recovering expectant mother program.
     8          2577. Newborn screening.
     9          2578. Provider education.
    10          2579. Workgroup.
    11    § 2576. Recovering  expectant  mother  program.  There shall be estab-
    12  lished a recovering expectant  mothers  program  within  the  department
    13  whereby  the  commissioner,  in  consultation  with  the commissioner of
    14  addiction services and supports, shall provide guidance,  education  and
    15  assistance  to  providers caring for recovering expectant mothers, which
    16  shall include, but not be limited to:
    17    1. establishing, in consultation with relevant health care  providers,
    18  guidance on universal screening techniques for substance use disorder at
    19  prenatal  visits.  Such guidance shall rely on validated screening tools
    20  and questionnaires and utilize language to help reduce stigma;
    21    2. providing information regarding use of medication  assisted  treat-
    22  ment  for  pregnant  women,  which  shall  include information regarding
    23  buprenorphine training, tools for providers on effective  management  of
    24  women  with  opioid  use  disorder  in pregnancy, and a referral list of
    25  certified providers;
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01029-01-3

        A. 317                              2
 
     1    3. providing referral  information  for  substance  abuse  counseling,
     2  social support and basic needs referrals, which shall also include guid-
     3  ance  on  referring  women  to  home  visiting services that they may be
     4  eligible for after birth; and
     5    4.  developing  a  system  for rapid consultation and referral linkage
     6  services for obstetricians and  primary  care  providers  statewide  who
     7  provide care for expectant mothers with substance use disorder.
     8    § 2577. Newborn  screening.  The commissioner, in conjunction with the
     9  commissioner of addiction services and supports, shall develop  guidance
    10  for  hospitals  and  midwifery  birth  centers  on  neonatal  abstinence
    11  syndrome which shall include, but not be limited to, appropriate  treat-
    12  ment  methods  for  neonatal abstinence syndrome and information on home
    13  visiting services that recovering mothers may be eligible for,  as  well
    14  as  other  substances  abuse  services,  social  supports and basic need
    15  referrals in the community.
    16    § 2578. Provider education. The commissioner shall develop or  approve
    17  a  continuing  medical  education  course for neonatal nurses, obstetri-
    18  cians, midwives, pediatricians, and other health care providers  regard-
    19  ing  treatment  of  expectant  mothers  and  new  mothers suffering from
    20  substance use disorder, and the treatment  of  newborns  suffering  from
    21  neonatal  abstinence  syndrome,  which  may  include  federally approved
    22  buprenorphine training, in order to  facilitate  comprehensive  prenatal
    23  and postpartum care to this population.
    24    § 2579.   Workgroup. The commissioner, in conjunction with the commis-
    25  sioner of addictions services and supports, shall convene a workgroup of
    26  stakeholders, including but not  limited  to,  hospitals,  local  health
    27  departments, obstetricians, midwives, pediatricians, and substance abuse
    28  providers to study and evaluate current barriers and challenges in iden-
    29  tifying  and  treating expectant mothers, newborns, and new parents with
    30  substance use disorder. The workgroup shall report on its  findings  and
    31  recommendations to the commissioner, the speaker of the assembly and the
    32  temporary  president of the senate within one year of the effective date
    33  of this section.
    34    § 3. This act shall take effect on the ninetieth day  after  it  shall
    35  have  become a law. Effective immediately the addition, amendment and/or
    36  repeal of any rule or regulation necessary  for  the  implementation  of
    37  this  act  on its effective date are authorized to be made and completed
    38  on or before such date.
Go to top